Assessing cognition in Alzheimer disease research

Alzheimer Disease and Associated Disorders

Volumn 11, Issue SUPPL. 6, 1997, Pages 45-49

  Ferris, Steven H ^a   Kluger, Alan ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer disease; Cognition; Cognitive assessment; Neuropsychology; Psychometric testing

Indexed keywords

ALZHEIMER DISEASE; COGNITION; HUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSYCHOMETRY; REVIEW;

ALZHEIMER DISEASE; COGNITION; HEALTH SERVICES RESEARCH; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES;

EID: 0031474319     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994.
2. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and senile change in the cerebral gray matter of elderly subjects. Br J Psychiatry 1968;114:797-811.
3. Blessed G, Tomlinson BE, Roth M. Blessed-Roth dementia scale (DS). Psychopharmacol Bull 1988;24:705-8.
4. Burns A, Jacoby R, Levy R. Progression of cognitive impairment in Alzheimer's disease. J Am Geriatr Soc 1991;39:39-45.
5. Cockrell JR, Folstein MF. Mini-Mental State Examination (MMSE). Psychopharmacol Bull 1988;24:689-92.
6. Erzigkeit H. The SKT - a short cognitive performance test as an instrument for the assessment of clinical efficacy of cognition enhancers. In: Bergener M, Reisberg B, eds. Diagnosis and treatment of senile dementia. Berlin: Springer-Verlag, 1989:164-74.
7. Ferris SH, Crook T, Flicker C, Reisberg B, Bartus RT. Assessing cognitive impairment and evaluating treatment effects: psychometric performance tests. In: Poon LW, ed. The handbook for clinical memory assessment of older adults. Washington, DC: American Psychological Association, 1986:108-28.
8. Ferris SH, Flicker C, Reisberg B. NYU computerized test battery for assessing cognition in aging and dementia. Psychopharmacol Bull 1988;24:699-702.
9. Ferris SH, Mackell JA, Mohs R, et al. A multicenter evaluation of new treatment efficacy instruments for Alzheimer disease clinical trials: overview and general results. Alzheimer Dis Assoc Disord 1997; 11(Suppl 2):S1-12.
10. Flicker C. Neuropsychological evaluation of treatment effects in the elderly: a critique of tests in current use. Psychopharmacol Bull 1988; 24:535-56.
11. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12:189-98.
12. Gilbert JG, Levee RF. Patterns of declining memory. J Gerontol 1971;26:70-5.
13. Hersch EL. Development and application of the extended scale for dementia. J Am Geriatr Soc 1979;26:348-54.
14. Katzman R, Brown T, Fuld P, Peck A, Schlechter R, Schimmel H. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry 1983;140:734-9.
15. Kluger A, Gianutsos JC, Golomb J, Ferris SH, George AE, Franssen E, Reisberg B. Patterns of motor impairment in normal aging, mild cognitive decline and early Alzheimer's disease. J Gerontol Psychol Sci 1997;52B:28-39.
16. Larrabee GJ, Crook T. A computerized everyday memory battery for assessing treatment effects. Psychopharmacol Bull 1988;24: 695-7.
17. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellack R, Karasu B, eds. Geriatric psychiatry. New York: Grune & Stratton, 1976:77-121.
18. Mattis S. Dementia rating scale professional manual. Odess, FL: Psychological Assessment Resources Inc, 1988.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
20. Mohs R, Knopman D, Peterson R, et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale (ADAS) that broaden its scope. Alzheimer Dis Assoc Disord 1997;11(Suppl 2):S13-21.
21. Mohs RC, Cohen L. Alzheimer's disease assessment scale (ADAS). Psychopharmacol Bull 1988;24:627-8.
22. Molloy DW, Alemayehu E, Roberts R. A standardized Mini-Mental State Examinadon (SMMSE): its reliability compared to the traditional Mini-Mental State Examination (MMSE). Am J Psychiatry 1991;148:102-5.
23. Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A. Consortium to Establish a Registry for Alzheimer's Disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull 1988;24:641-52.
24. Moss MB, Albert MS. Alzheimer's disease and other dementing disorders. In: Albert MS, Moss MB, eds. Geriatric neuropsychology. New York: Guilford Press, 1988:145-78.
25. Murden RA, McRae TD, Kaner S, Bucknam ME. Mini-Mental State Exam scores vary with education in blacks and whites. J Am Geriatr Soc 1991;39:149-55.
26. O'Connor DW, Pollitt PA, Hyde JB, et al. The reliability and validity of the mini-mental state in a British community survey. J Psychiatr Res 1989;23:87-96.
27. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale (GDS). Psychopharmacol Bull 1988;24:661-3.
28. Reisberg B, Ferris SH, Kluger A, et al. Symptomatic changes in CNS aging and dementia of the Alzheimer type: cross-sectional, temporal, and remediable concomitants. In: Bergener M, Reisberg B, eds. Diagnosis and treatment of senile dementia. Berlin: Springer-Verlag, 1989a:193-223.
29. Reisberg B, Ferris SH, Steinberg G, Shulman E, de Leon MJ, Sinaiko E. Longitudinal study of dementia patients and aged controls: an approach to methodologic issues. In: Lawton MP, Herzog AR, eds. Special research methods for gerontology. Amityville, NY: Baywood Publishers, 1989b:195-231.
30. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;14:1356-64.
31. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX: a standard instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149: 698-709.
32. Sano M, Ferris SH, Pontone M, et al. Alzheimer's disease treatment efficacy instruments for Spanish speakers: protocol design and implementation. Alzheimer Dis Assoc Disord 1997;11(Suppl 2):S57-64.
33. Schmidt F, Ashford W, Ernesto C, et al. The Severe Impairment Battery (SIB): concurrent validity and the assessment of longitudinal change in Alzheimer's disease. Alzheimer Dis Assoc Disord 1997;11(Suppl 2): S51-6.
34. Simpson PM, Surmon DJ, Wesnes KA, Wilcock GR. The cognitive drug research computerised assessment system for demented patients: a validation study. Int J Geriatr Psychiatry 1991;6:95-102.
35. Stern RG, Mohs RC, Davidson M, et al. A longitudinal study of Alzheimer's disease: measurement, rate and predictors of cognitive deterioration. Am J Psychiatry 1994;151:390-6.
36. Wechsler D. Wechsler memory scale - revised. San Antonio, TX: Psychological Corporation/Harcourt Brace Jovanovich, 1987.